Recro Pharma (REPH) Misses Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts REPH Hot Sheet
Join SI Premium – FREE
Recro Pharma (NASDAQ: REPH) reported Q3 EPS of ($0.61), $0.10 worse than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Recro Pharma (REPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
